BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT)

Last Price12.04

Change+0.53 (4.60%)

NASDAQ · Last Trade: Jan 14th, 5:57 PM EST

Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?

Via The Motley Fool · December 22, 2025